Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, Mozambique.

Autor: de Deus N; Instituto Nacional de Saúde (INS), Maputo, Mozambique., Capitine IPU; Instituto Nacional de Saúde (INS), Maputo, Mozambique., Bauhofer AFL; Instituto Nacional de Saúde (INS), Maputo, Mozambique.; Instituto de Higiene e Medicina Tropical-Universidade Nova de Lisboa, Lisboa, Portugal., Marques S; Instituto Nacional de Saúde (INS), Maputo, Mozambique., Cassocera M; Instituto Nacional de Saúde (INS), Maputo, Mozambique.; Instituto de Higiene e Medicina Tropical-Universidade Nova de Lisboa, Lisboa, Portugal., Chissaque A; Instituto Nacional de Saúde (INS), Maputo, Mozambique.; Instituto de Higiene e Medicina Tropical-Universidade Nova de Lisboa, Lisboa, Portugal., Bero DM; Instituto Nacional de Saúde (INS), Maputo, Mozambique., Langa JP; Instituto Nacional de Saúde (INS), Maputo, Mozambique., Padama FM; Direcção Provincial de Saúde da Zambézia, Mozambique., Jeyaseelan V; Polio Eradication Department, World Health Organization, Geneva, Switzerland., Oberste MS; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Estivariz CF; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Verma H; Polio Eradication Department, World Health Organization, Geneva, Switzerland., Jani I; Instituto Nacional de Saúde (INS), Maputo, Mozambique., Mach O; Polio Eradication Department, World Health Organization, Geneva, Switzerland., Sutter RW; Polio Eradication Department, World Health Organization, Geneva, Switzerland.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2022 Aug 24; Vol. 226 (2), pp. 292-298.